The KRW 43 billion ‘Vytorin Tab’ market is noticed by 23 generic products

Published: 2015-06-29 14:33:08

Updated: 2015-06-29 14:33:08

Domestic pharmaceutical companies have kept eyes on the hyperlipidemia treatment ‘Vytorin Tab’ market, which used to worth KRW 43 billion last year.

According to the Ministry of Food and Drug Safety, 12 pharmaceutical companies in Korea have acquired approvals for 23 ‘Vytorin Tab(ezetimibe+simvastatin complex)’ generic products and is getting ready to enter the market.

The MSD Korea’s ‘Vytori...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.